Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol

Madhumita Roy1, Sutapa Chakrabarty, Dona Sinha

  • 1Department of Environmental Carcinogenesis and Toxicology, Chittaranjan National Cancer Institute, 37 SP Mukherjee Road, Kolkata 700 026, India.

Mutation Research
|March 12, 2003
PubMed

Insights

Epigallocatechin gallate (EGCG) from green tea protects normal cells from DNA damage and carcinogens. EGCG also eliminates human leukemia cells by inducing apoptosis, offering a dual cancer-protective strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Cancer control strategies focus on modulating carcinogenesis and cancer cell behavior.
  • Green tea polyphenol epigallocatechin gallate (EGCG) is recognized for its cancer chemopreventive properties.
  • EGCG influences cellular and molecular events crucial to carcinogenesis.

Purpose of the Study:

  • To investigate the effects of EGCG on cytogenetic damage and DNA damage induced by hydrogen peroxide (H2O2) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
  • To evaluate EGCG's role in inducing apoptosis in cancer cells, specifically human chronic myelogenic leukemia K-562 cells.

Main Methods:

  • Chinese hamster V-79 cells were exposed to H2O2 and MNNG, with and without EGCG pre-incubation.
  • Cytogenetic damage assessed via micronucleus formation.
  • DNA damage evaluated using single-cell gel electrophoresis (comet assay).
  • K-562 cell proliferation and apoptosis induction were analyzed morphologically and biochemically (DNA fragmentation, caspase activation).

Main Results:

  • EGCG significantly suppressed MNNG- and H2O2-induced cytogenetic damage and DNA damage in a dose-dependent manner.
  • Pre-incubation with EGCG protected V-79 cells from genotoxic agent-induced damage.
  • EGCG inhibited growth and proliferation of K-562 leukemia cells.
  • EGCG induced apoptosis in K-562 cells, evidenced by morphological changes and DNA fragmentation, mediated by caspase 3 and caspase 8 activation.

Conclusions:

  • EGCG demonstrates a dual role in cancer prevention and therapy.
  • It protects normal cells against genotoxic damage, thereby acting as a chemopreventive agent.
  • EGCG effectively eliminates cancer cells, such as leukemia cells, through the induction of apoptosis, suggesting therapeutic potential.

Related Concept Videos